Director, Business Development

Invivoscribe is an industry pioneer and global leader in precision oncology diagnostics. For more than 30 years, we have driven international standardization of molecular and flow cytometry testing and expanded access to advanced cancer therapies worldwide. Our mission is simple and unwavering: Improving Lives with Precision Diagnostics®.

We are seeking a strategic, entrepreneurial, and relationship-focused Director, Business Development to expand Invivoscribe’s global footprint across the pharmaceutical, biotechnology, and diagnostics sectors. This is a high-impact leadership role for a true dealmaker—someone who excels at the intersection of science, strategy, and commercialization. You will architect and execute partnerships that accelerate adoption of our assays, services, and emerging offerings, helping shape the future of precision oncology.

Headquartered in San Diego, with operations across North America, Europe, and Asia, Invivoscribe develops and manufactures a comprehensive portfolio of molecular and flow cytometry assays, reagents, controls, and bioinformatics tools under ISO 13485 design control. Our products and services support more than 700 clinical laboratories in over 160 countries.

Location: This role is based at our San Diego Headquarters. Consideration will be given to remote candidates located in the Northeast, with a preference for candidates in the Boston area.

Core Responsibilities

Strategic Partnership Development

• Identify, cultivate, and manage high-value partnerships across pharma, biotech, clinical laboratories, and diagnostic technology companies.
• Develop strategic frameworks that align partner needs with Invivoscribe solutions, including CDx co-development, clinical trial support, and global testing programs.

Negotiation & Deal Execution

• Lead the full deal lifecycle, including opportunity evaluation, structuring, negotiation, contracting, and operational transition.
• Drive strategic collaborations, licensing agreements, technology access deals, and companion diagnostic partnerships.

Market & Competitive Insight

• Deliver actionable insights on market trends, competitive dynamics, customer needs, and emerging scientific advancements.
• Inform portfolio strategy, new product opportunities, and geographic market expansion.

Commercial & Scientific Growth Enablement

• Translate complex scientific capabilities into compelling commercial opportunities and business cases.
• Partner cross-functionally with R&D, Product Management, Regulatory, Finance, and Commercial teams to operationalize and scale partnerships.

Core Requirements

• Established network and strong relationships across pharma, biotech, and/or diagnostics to accelerate partnership development.
• Proven success navigating and closing complex deal structures, including CDx, licensing, co-development, and international collaborations.
• Solid understanding of drug development, flow cytometry, molecular diagnostics, clinical research, or advanced biotechnology platforms.
• Bachelor’s degree in Life Sciences, Biotechnology, Business, or a related field; 10+ years of business development experience in biotech, pharma, or life sciences with a strong record of closing high-impact partnerships.
• Advanced degree (MBA, MS, PhD, MPH) preferred; equivalent experience considered.
• Resilient and driven. Dealmaker mentality: able to open doors to new opportunities, negotiate, and close high-value, complex deals.
• Adept at influencing stakeholders both direct and indirect, internal and external.

Why Join Us

At Invivoscribe, you will join a mission-driven global organization advancing the future of precision oncology. You will have the opportunity to shape major scientific and commercial partnerships that impact patients around the world.

We offer:

• Competitive compensation and performance incentives
• Comprehensive global benefits
• A collaborative, innovation-driven culture
• The opportunity to make a significant global impact in precision medicine

If you are strategic, relationship-driven, and energized by high-impact dealmaking in the life sciences, we look forward to speaking with you.